Loading...
Loading...
Among the 3 tracked institutional investors we monitor, KPRX (KIORA PHARMACEUTICALS INC) is held with a combined value of $160.90K across 82,682 shares. The largest holder is CITADEL ADVISORS LLC with a position worth $95.60K (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 1 fund increased its holdings.
Total Institutional Value
$160.90K
Total Shares Held
82,682
Institutional Holders
3
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | $95.60K | 0.00% | +121.3% |
| 2 | VANGUARD GROUP INC | $65.19K | 0.00% | New |
| 3 | BlackRock, Inc. | $112 | 0.00% | - |
As of the latest SEC 13F filings, CITADEL ADVISORS LLC is the largest institutional holder of KPRX with a position worth $95.60K, representing 0.00% of their portfolio. In total, 3 institutional investors hold KPRX with a combined value of $160.90K.
In the most recent quarter, 1 fund opened a new position in KPRX. Additionally, 1 increased their holdings.
Institutional investors hold $160.90K worth of KPRX stock across 3 positions. The largest institutional holder is CITADEL ADVISORS LLC with $95.60K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For KPRX, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their KPRX positions.